期刊
INTERNATIONAL JOURNAL OF CANCER
卷 148, 期 5, 页码 1208-1218出版社
WILEY
DOI: 10.1002/ijc.33366
关键词
Africa; Cytosponge; esophageal cancer; squamous dysplasia
类别
资金
- International Agency for Research on Cancer (IARC)
- Chemistry Biology Interface Division (CBID) of the Royal Society of Chemistry (RSC)
- European Commission FP7 Marie Curie Actions-People-Co-funding of regional, national and international programmes (COFUND)
Esophageal sponge cytology is a well-accepted endoscopy alternative for adenocarcinoma with extensive data on accuracy, but its feasibility in asymptomatic community members, particularly in East Africa with high ESCC rates, has been less studied. In a study of 102 asymptomatic adults in Kilimanjaro, Tanzania, the safety, acceptability, and feasibility of Cytosponge sampling was demonstrated, paving the way for innovative etiology and early-detection research. Targeted sampling strategies and biomarker development will be crucial for the success of future initiatives.
Esophageal sponge cytology is an endoscopy alternative well accepted by patients with extensive data for accuracy in the context of adenocarcinoma. Few studies have assessed its feasibility in asymptomatic community members, and fewer still in East Africa, where esophageal squamous cell carcinoma (ESCC) rates are high. We aimed to assess the feasibility of a capsule-based diagnosis of esophageal squamous dysplasia (ESD), an ESCC precursor, which may benefit epidemiological and early detection research. We collected Cytosponge collections in 102 asymptomatic adults from Kilimanjaro, Tanzania. Uptake, acceptability and safety were assessed. Participants scored acceptability immediately following the procedure and 7 days later on a scale of 0 (least) to 10 (most acceptable). Slides from paraffin-embedded cell clots were read by two pathologists for ESD and other pathologies. All participants (52 men, 50 women, aged 30-77) swallowed the device at first attempt, 100 (98%) of which gave slides of adequate cellularity. Acceptability scores were 10 (53%), 9 (24%), 8 (21%), 7 (2%) and 6 (1%), with no differences by age, sex or time of asking. Cytological findings were esophageal inflammation (4%), atypical squamous cells of uncertain significance (1%), low-grade dysplasia (1%), gastritis (22%) and suspected intestinal metaplasia (6%). Setting-specific logistical and ethical considerations of study implementation are discussed. We demonstrate the safety, acceptability and feasibility of Cytosponge sampling in this setting, paving the way for innovative etiology and early-detection research. Targeted sampling strategies and biomarker development will underpin the success of such initiatives. The study protocol is registered on (NCT04090554).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据